CS255878B2 - Process for preparing embonates of qinolcarboxylic acids and derivatives thereof - Google Patents

Process for preparing embonates of qinolcarboxylic acids and derivatives thereof Download PDF

Info

Publication number
CS255878B2
CS255878B2 CS865351A CS535186A CS255878B2 CS 255878 B2 CS255878 B2 CS 255878B2 CS 865351 A CS865351 A CS 865351A CS 535186 A CS535186 A CS 535186A CS 255878 B2 CS255878 B2 CS 255878B2
Authority
CS
Czechoslovakia
Prior art keywords
acid
derivatives
group
acids
embonates
Prior art date
Application number
CS865351A
Other languages
Czech (cs)
English (en)
Other versions
CS535186A2 (en
Inventor
Klaus Grohe
Herbert Voege
Arundev H Naik
Martin Scheer
Manfred Federmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CS535186A2 publication Critical patent/CS535186A2/cs
Publication of CS255878B2 publication Critical patent/CS255878B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/15—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing more than two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
CS865351A 1985-07-16 1986-07-14 Process for preparing embonates of qinolcarboxylic acids and derivatives thereof CS255878B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853525335 DE3525335A1 (de) 1985-07-16 1985-07-16 Embonate von chinoloncarbonsaeuren und ihren derivaten

Publications (2)

Publication Number Publication Date
CS535186A2 CS535186A2 (en) 1987-07-16
CS255878B2 true CS255878B2 (en) 1988-03-15

Family

ID=6275883

Family Applications (1)

Application Number Title Priority Date Filing Date
CS865351A CS255878B2 (en) 1985-07-16 1986-07-14 Process for preparing embonates of qinolcarboxylic acids and derivatives thereof

Country Status (20)

Country Link
EP (1) EP0209000B1 (ko)
JP (1) JPH0772177B2 (ko)
KR (1) KR940002823B1 (ko)
AR (1) AR242570A1 (ko)
AT (1) ATE55600T1 (ko)
AU (1) AU582255B2 (ko)
BR (1) BR8603333A (ko)
CA (1) CA1262350A (ko)
CS (1) CS255878B2 (ko)
DE (2) DE3525335A1 (ko)
DK (1) DK168042B1 (ko)
ES (1) ES2000678A6 (ko)
FI (1) FI88389C (ko)
GR (1) GR861823B (ko)
HU (1) HU194151B (ko)
IE (1) IE58750B1 (ko)
IL (1) IL79399A (ko)
NZ (1) NZ216815A (ko)
PL (1) PL149651B1 (ko)
ZA (1) ZA865256B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE502004011696D1 (de) * 2003-02-10 2010-11-11 Bayer Schering Pharma Ag Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2397903A (en) * 1944-09-19 1946-04-02 Vick Chemical Company Methylene-bis-2 hydroxy-3 naphthoates
US2641610A (en) * 1950-10-27 1953-06-09 May & Baker Ltd Quaternary ammonium salts
JPS5762259A (en) * 1980-09-05 1982-04-15 Kyorin Pharmaceut Co Ltd Preparation of substituted quinolinecarboxylic acid derivative
US4382937A (en) * 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
ES8304117A1 (es) * 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
IE861889L (en) 1987-01-16
DE3673476D1 (de) 1990-09-20
JPS6219569A (ja) 1987-01-28
DK335386D0 (da) 1986-07-15
NZ216815A (en) 1988-10-28
JPH0772177B2 (ja) 1995-08-02
PL149651B1 (en) 1990-03-31
AU6006286A (en) 1987-01-22
IE58750B1 (en) 1993-11-03
ATE55600T1 (de) 1990-09-15
FI862942A (fi) 1987-01-17
BR8603333A (pt) 1987-02-24
CA1262350A (en) 1989-10-17
FI862942A0 (fi) 1986-07-14
KR940002823B1 (ko) 1994-04-04
ES2000678A6 (es) 1988-03-16
DE3525335A1 (de) 1987-01-22
CS535186A2 (en) 1987-07-16
ZA865256B (en) 1987-03-25
FI88389B (fi) 1993-01-29
GR861823B (en) 1986-11-11
AR242570A1 (es) 1993-04-30
FI88389C (fi) 1993-05-10
EP0209000A3 (en) 1988-05-25
DK168042B1 (da) 1994-01-24
IL79399A0 (en) 1986-10-31
EP0209000A2 (de) 1987-01-21
DK335386A (da) 1987-01-17
EP0209000B1 (de) 1990-08-16
HUT42427A (en) 1987-07-28
AU582255B2 (en) 1989-03-16
PL260626A1 (en) 1987-06-15
KR870001210A (ko) 1987-03-12
IL79399A (en) 1990-08-31
HU194151B (en) 1988-01-28

Similar Documents

Publication Publication Date Title
US5145853A (en) Bactericidal formulations for use in veterinary medicine
US4762831A (en) Antibacterial 1,8-bridged 4-quinolone-3-carboxylic acids
US6967205B1 (en) Compounds with antibacterial and antiparasitic properties
CA2263584C (en) Orally applicable formulation of quinolone or naphthyridone carboxylic acids
NZ331468A (en) Substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4,3.0]-nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
EP1355629B1 (en) Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids
CS255878B2 (en) Process for preparing embonates of qinolcarboxylic acids and derivatives thereof
EP0828715B1 (de) N-oxide als antibakterielle mittel
JP2000501110A (ja) ピリド（３，２，１―ｉｊ）―１，３，４―ベンゾオキサジアジン
AU720322B2 (en) 7-(3-Vinyl-1,4-piperazin-1-yl)-substituted quinolonecarboxylic acids
JPH0565512B2 (ko)
JPH03218312A (ja) 動物用細菌感染症予防、治療剤

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20010714